COLLEYVILLE, TEXAS - November 3, 2009 – In recognition of American Diabetes Month and World Diabetes Day on November 14, Dr. Richard Driscoll urges community members to schedule yearly eye exams, particularly those with diabetes or that are pre-disposed to diabetes. Approximately 25 million Americans have diabetes, representing 7% of the population, and 6.2 million Americans remain undiagnosed. There were 1.5 million newly diagnosed cases of diabetes in people ages 20 years or older in 2005 demonstrating that diabetes is rapidly becoming one of the most important health care issues.
“Regular eye exams are crucial for individuals of all ages, particularly those with diabetes or that are pre-disposed to diabetes. The earliest signs of diabetic eye complications often occur without warning,” said Dr. Alycia Green of Total Eye Care. “I encourage community members to have their eyes examined with the optomap® Retinal Exam, the latest in eye care technology, that provides information that can help with the early detection of diabetes and eye related conditions.”
Diabetic retinopathy causes 12,000 to 24,000 new cases of blindness each year making diabetes the leading cause of blindness in adults 20-74 years of age. Regular eye exams can help detect diabetic retinopathy in the early stages to prescribe effective treatment plans.
The optomap® Retinal Exam is fast, easy, and painless for patient of all ages and provides eye care practitioners with clinically useful information about the health of the retina, the back of the eye. The optomap® also provides the ability to monitor changes in the retina and compare images over time, a valuable tool when monitoring patients with diabetes related eye conditions such as diabetic retinopathy.
# # #
Therapeutic Optometrist and Optometric
Glaucoma Specialist
Dr. Richard
Driscoll has been serving the eye care needs of
###
Dr. Richard Driscoll
Total Eye Care
817.416.0333
Press @ totaleyecare.NET
Optos plc is a leading and rapidly growing medical technology company for the design, development, manufacturing and marketing of devices that image the retina, the light-sensitive area at the back of the eye. Optos' platform technology is the Panoramic200 Scanning Laser Ophthalmoscope device - known as the P200. In a quarter of a second the P200 device produces a high resolution image of up to 200 degrees or approximately 82 percent of the retina in a single capture. The image - branded the optomap® Retinal Exam - provides eye care practitioners with clinically useful information that facilitates the early detection of disorders and diseases evidenced in the retina, such as glaucoma, diabetic retinopathy and age-related macular degeneration. Retinal imaging can also indicate evidence of non-eye or systemic diseases such as diabetes, hypertension and certain cancers.
# # #